No Data
Astellas Pharma To Go Ex-Dividend On March 30th, 2026 With 39 JPY Dividend Per Share
April 26th (Japan Standard Time) - $Astellas Pharma(4503.JP)$ is trading ex-dividend on March 30th, 2026.Shareholders of record on March 31st, 2026 will receive 39 JPY dividend per share. The ex-
Astellas Pharma To Go Ex-Dividend On September 29th, 2025 With 39 JPY Dividend Per Share
April 26th (Japan Standard Time) - $Astellas Pharma(4503.JP)$ is trading ex-dividend on September 29th, 2025.Shareholders of record on September 30th, 2025 will receive 39 JPY dividend per share.
Key points of attention for the PTS on the 25th = Advantest, Anritsu, Shin-Etsu Chemical, Fujitsu, ETC.
▽ Advantest <6857.T>, the consolidated operating profit Financial Estimates for the fiscal year ending March 2026 is 242 billion yen (a 6% increase compared to the previous period). The assumed Exchange Rates are 140 yen to 1 dollar and 155 yen to 1 euro. It is viewed that the impact of tariff measures on business and performance is minimal. ▽ Anritsu <6754.T>, the consolidated operating profit Financial Estimates for the fiscal year ending March 2026 is 15 billion yen (a 24% increase compared to the previous period). Formulated based on the situation before the tariff measures by the USA are implemented. ▽ Shin-Etsu Chemical <4063.T>, the first quarter of the fiscal year ending March 2026 (
Astellas Pharma: Recording of fair value fluctuations related to conditional consideration and differences between consolidated earnings forecasts for the fiscal year ending 2025/3 and actual values
Astellas Pharma: Supplementary financial results for the fiscal year ending March 2025
Astellas Pharma: Financial results briefing materials for the fiscal year ending March 2025
